US Healthcare Bill passing is keeping Indian Pharma Active http://akprabhakar.blogspot.com/2009/12/us-healthcare-bill-passing-is-keeping.html
Healthcare bill advancing in U.S senate would keep select Indian Pharma stocks active and Indian Pharma companies have made a massive a come-back on Dalal Street. JUBILANT ORGANOSYS - Buy for solid returns Jubilant Organosys (JOL) is an integrated pharmaceutical industry player, one of the largest Custom Research and Manufacturing Services(CRAMS) and Drug Discovery and Development Services (DDDS) companies out of India. Post two acquisitions, JOL’s custom manufacturing operations (CMO) have a strong edge in the niche sterile injectables space. JOL already services six of the world’s top ten pharma MNCs. http://www.ibef.org/download/jubilant_organosys_23oct.pdf Jubilant Organosys http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=111_cong_bills&docid=f:h3962pcs.txt.pdf Affordable Health Care for America Act (Placed on Calendar in Senate) http://prabhakar-views.blogspot.com/2009/12/nuclear-deals-with-india.htmlWhy was the Nuke Deal so important? India, Canada sign nuclear pact .. World’s biggest uranium firm coming to India http://www.thaindian.com/newsportal/business/worlds-biggest-uranium-firm-coming-to-india_100282977.html India, Russia sign Nuclear deal Regards A.K.Prabhakar Equity Analyst [email protected] [email protected] * * http://akprabhakar.blogspot.com http://prabhakar-views.blogspot.com *Disclaimer:*** *This represents views based purely on Technical studies. The information and views presented in this report are prepared by A K Prabhakar. The information contained herein is based on my analysis of the Charts and upon sources that I consider reliable. I, however, do not vouch for the accuracy or the completeness thereof. This material is for personal information and I am not responsible for any loss incurred based upon it. The investments discussed or recommended in this report may not be suitable for all investors. Investors must make their own investment decisions based on their specific investment objectives and financial position and using such independent advice, as they believe necessary. While acting upon any information or analysis mentioned in this report, investors may please note that neither A K Prabhakar nor any person connected with him accepts any liability arising from the use of this information and views mentioned in this document. A K Prabhakar and his affiliates may hold long or short positions in the above-mentioned companies from time to time. The report is intended for a restricted audience and I am not soliciting any action based on it. Neither the information nor any opinion expressed herein constitutes an offer or an invitation to make an offer, to buy or sell any securities, or any options, futures or other derivatives related to such securities. * -- You received this message because you are subscribed to the Google Groups ""GLOBAL SPECULATORS"" group. To post to this group, send email to [email protected]. To unsubscribe from this group, send email to [email protected]. For more options, visit this group at http://groups.google.com/group/globalspeculators?hl=en.
